BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 3, 2018
View Archived Issues
Nudt15-knockout mouse model shown useful to guide thiopurine dosing in ALL
Read More
Atara Biotherapeutics announces initiation of phase III clinical program for tabelecleucel
Read More
First patient dosed in phase III trial of tislelizumab in HCC
Read More
Cascadian Therapeutics receives pediatric investigation plan waiver from EMA for tucatinib
Read More
NexImmune closes series A financing to support initiation of phase I/II trial of AIM ACT
Read More
IQGAP1 identified as a potential therapeutic target for AML treatment
Read More
Protalix BioTherapeutics reports interim data from phase II study of OPRX-106
Read More
FDA grants priority review to Achaogen's plazomicin NDA
Read More
Centrexion Therapeutic raises funds for phase III development of CNTX-4975
Read More
Five Prime initiates phase I portion of FIGHT trial of FPA-144 in advanced gastric cancer
Read More
FDA grants breakthrough therapy designation to Kisqali for premenopausal breast cancer
Read More
Achaogen reports topline results from first clinical trial of C-Scape
Read More
Tetraphase submits NDA for intravenous eravacycline to treat cIAI
Read More
FDA accepts Olinvo NDA
Read More
New anti-BCMA-CAR therapy for MM shows promise in preclinical phase
Read More
Addex and Indivior sign licensing and collaboration agreement for ADX-71441 to treat addiction
Read More
SciFluor Life Sciences patents novel KCNQ2/3 activators
Read More
Chinese researchers disclose kappa-opioid receptor agonists
Read More
Enanta Pharmaceuticals identifies anti-HBV compounds
Read More
Bayer presents novel IRAK-4 inhibitors
Read More
New TBK1 and IKK-E inhibitors presented by Bayer
Read More
Researchers present novel BALB/c mouse model of PRV infection
Read More
Galapagos updates status of cystic fibrosis pipeline
Read More